Research ArticleClinical Investigations
Differential 18F-FDG and 18F-FLT Uptake on Serial PET/CT Imaging Before and During Definitive Chemoradiation for Non–Small Cell Lung Cancer
Sarah J. Everitt, David L. Ball, Rodney J. Hicks, Jason Callahan, Nikki Plumridge, Marnie Collins, Alan Herschtal, David Binns, Tomas Kron, Michal Schneider and Michael MacManus
Journal of Nuclear Medicine July 2014, 55 (7) 1069-1074; DOI: https://doi.org/10.2967/jnumed.113.131631
Sarah J. Everitt
1Radiation Therapy, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia
2Department of Medical Imaging and Radiation Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia
3Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia
David L. Ball
3Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia
4Division of Radiation Oncology, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia
Rodney J. Hicks
3Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia
5Centre for Cancer Imaging, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia
Jason Callahan
2Department of Medical Imaging and Radiation Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia
5Centre for Cancer Imaging, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia
Nikki Plumridge
4Division of Radiation Oncology, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia
Marnie Collins
6Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; and
Alan Herschtal
6Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; and
David Binns
5Centre for Cancer Imaging, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia
Tomas Kron
2Department of Medical Imaging and Radiation Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia
3Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia
7Department of Physical Sciences, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia
Michal Schneider
2Department of Medical Imaging and Radiation Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia
Michael MacManus
3Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia
4Division of Radiation Oncology, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 55, Issue 7
July 1, 2014
Differential 18F-FDG and 18F-FLT Uptake on Serial PET/CT Imaging Before and During Definitive Chemoradiation for Non–Small Cell Lung Cancer
Sarah J. Everitt, David L. Ball, Rodney J. Hicks, Jason Callahan, Nikki Plumridge, Marnie Collins, Alan Herschtal, David Binns, Tomas Kron, Michal Schneider, Michael MacManus
Journal of Nuclear Medicine Jul 2014, 55 (7) 1069-1074; DOI: 10.2967/jnumed.113.131631
Differential 18F-FDG and 18F-FLT Uptake on Serial PET/CT Imaging Before and During Definitive Chemoradiation for Non–Small Cell Lung Cancer
Sarah J. Everitt, David L. Ball, Rodney J. Hicks, Jason Callahan, Nikki Plumridge, Marnie Collins, Alan Herschtal, David Binns, Tomas Kron, Michal Schneider, Michael MacManus
Journal of Nuclear Medicine Jul 2014, 55 (7) 1069-1074; DOI: 10.2967/jnumed.113.131631
Jump to section
Related Articles
Cited By...
- Predictive value of 3'-deoxy-3'-18F-fluorothymidine PET in the early response to anti-programmed death-1 therapy in patients with advanced non-small cell lung cancer
- 18F-FLT PET/CT Adds Value to 18F-FDG PET/CT for Diagnosing Relapse After Definitive Radiotherapy in Patients with Lung Cancer: Results of a Prospective Clinical Trial
- Predictive Value of Early-Stage Uptake of 3'-Deoxy-3'-18F-Fluorothymidine in Cancer Cells Treated with Charged Particle Irradiation